首頁 > 市場調查報告書 > 醫療設備

導管心血管設備

市場調查報告書

商品編碼

1491747

週邊干預市場規模、佔有率、成長分析、按產品、按應用、按最終用途 - 行業預測，2024-2031 年

Peripheral Interventions Market Size, Share, Growth Analysis, By Product(Catheters, Sheath), By Application(Venous Thromboembolism, Peripheral Artery Disease), By End-Use(Hospitals, Ambulatory Surgical Centres) - Industry Forecast 2024-2031

出版日期: 2024年06月06日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球外圍干預市場規模為86.8億美元，從2023年的94.2億美元成長到2031年的180.9億美元，預測期間（2024-2031年）預計複合年成長率為8.50%。

高血壓、糖尿病、肥胖、吸菸和高碳水化合物飲食等因素會導致多種心血管疾病。這種健康問題導致導管實驗室（cath labs）在全球範圍內激增，特別是在新興市場，隨著專門從事外周干預的醫療保健專業人員的增加，正在推動行業成長。導管實驗室在心血管疾病的診斷和治療中發揮重要作用，其使用正在增加，特別是在開發中國家，而混合導管實驗室的出現代表了最近的一項重要進展。這些可以進行心臟和周邊干預以及神經、電生理和其他臨床手術的混合設施正在增加。特別是在印度，隨著包括血管成形術在內的周邊干預措施的普及，導管實驗室的數量顯著增加，從而推高了全球醫療保健支出。隨著此類手術需求的持續成長，專家和導管實驗室的擴張預計將進一步推動產業成長。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- 其他中東/非洲地區

競爭格局

前5名企業對比
主要企業市場定位（2023年）
主要市場參與者所採取的策略
近期市集活動
主要企業市場佔有率（2023年）

主要企業簡介

Johnson & Johnson（United States）
Medtronic（United States）
Becton Dickinson（United States）
Boston Scientific Corporation（United States）
Abbott Laboratories（United States）
Terumo Corporation（Japan）
Cook Medical（United States）
Cardinal Health（United States）
CR Bard（United States）
Teleflex Incorporated（United States）
AngioDynamics Inc.（United States）
B. Braun Melsungen AG（Germany）
Asahi Intecc Co., Ltd.（Japan）
Penumbra, Inc.（United States）
Stryker Corporation（United States）
Terumo Interventional Systems（United States）
Olympus Corporation（Japan）
Nipro Corporation（Japan）
Endologix Inc.（United States）
Merit Medical Systems, Inc.（United States）

簡介目錄

Product Code: SQMIG35D2214

Global Peripheral Interventions Market size was valued at USD 8.68 billion in 2022 and is poised to grow from USD 9.42 billion in 2023 to USD 18.09 billion by 2031, growing at a CAGR of 8.50% during the forecast period (2024-2031).

The escalating prevalence of cardiovascular disorders (CVD) is becoming a major driver for demand in peripheral interventions, fueled by factors like hypertension, diabetes, obesity, smoking, and diets rich in carbohydrates contributing to various CVD types. This health concern has led to a proliferation of catheterization laboratories (cath labs) globally, especially in emerging markets, accompanied by a rise in healthcare professionals specializing in peripheral interventions, thus bolstering industry growth. Cath labs play a vital role in diagnosing and treating cardiovascular conditions, with their utilization increasing, particularly in developing nations, and the advent of hybrid cath labs marking a significant recent advancement. These hybrid facilities, adaptable for cardiac and peripheral interventions as well as neurological, electrophysiological, and other clinical procedures, are on the rise. Notably, India has seen a substantial increase in cath lab numbers, accompanied by a significant surge in peripheral intervention procedures, including angioplasties, consequently driving up global healthcare expenditure. With a projected continued rise in demand for these procedures, the expansion of specialized experts and catheterization laboratories is expected to further propel industry growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Peripheral Interventions Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Peripheral Interventions Market Segmental Analysis

The global peripheral interventions market is segmented on the basis of product, application, end-use, and region. By product, the market is segmented into catheters, sheath, stents, bare-metal stents, drug-eluting stents, guide wires, atherectomy devices, embolic devices, thrombectomy devices, IVC filters and others. By application, the market is segmented into venous thromboembolism, peripheral artery disease and others. By end-use, the market is segmented into hospitals, ambulatory surgical centers, catheterization laboratories and others. By region, the market is segmented into North America, Europe, Latin America, Asia- Pacific, Middle East and Africa.

Drivers of the Global Peripheral Interventions Market

The increasing frequency of cardiovascular disorders, encompassing conditions like peripheral artery disease (PAD), is fueling the demand for solutions targeting peripheral health. This surge in cardiovascular issues is mainly linked to risk factors such as hypertension, diabetes, obesity, and a sedentary lifestyle.

Restraints in the Global Peripheral Interventions Market

Limited market accessibility stems from the high costs associated with peripheral intervention treatments for certain individuals, potentially hindering access to essential care, particularly in affluent regions with expensive healthcare systems.

Market Trends of the Global Peripheral Interventions Market

The rising demand for invasive interventional treatments, including cardiac, vascular, neurological, and electrophysiological procedures, is driving the growth of hybrid catheterization labs, which are becoming increasingly popular. This expanding market is fueled by the versatility and adaptability of these facilities.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Patent Analysis
Ecosystem of the Market
Regulatory Landscape
Innovation Matrix
Top Investment Analysis
Key Success Factor
Degree of Competition

Peripheral Interventions Market by Product

Market Overview
Catheters
Sheath
Stents
Bare-meta Stents
Drug-eluting Stents
Guide Wires
Atherectomy Devices
Embolic Devices
Thrombectomy Devices
IVC Filters
Others

Peripheral Interventions Market by Application

Market Overview
Venous Thromboembolism
Peripheral Artery Disease
Others

Peripheral Interventions Market by End-use

Market Overview
Hospitals
Ambulatory Surgical Centres
Catheterization Laboratories
Others

Peripheral Interventions Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Johnson & Johnson (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton Dickinson (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cook Medical (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cardinal Health (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
C. R. Bard (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teleflex Incorporated (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AngioDynamics Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
B. Braun Melsungen AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Asahi Intecc Co., Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Penumbra, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stryker Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Interventional Systems (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Olympus Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nipro Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Endologix Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merit Medical Systems, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments